首页> 美国卫生研究院文献>Molecular Therapy >Efficient Reprogramming of Human Cord Blood CD34+ Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone
【2h】

Efficient Reprogramming of Human Cord Blood CD34+ Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone

机译:单独使用OCT4和SOX2将人脐血CD34 +细胞有效重编程为诱导多能干细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The reprogramming of cord blood (CB) cells into induced pluripotent stem cells (iPSCs) has potential applications in regenerative medicine by converting CB banks into iPSC banks for allogeneic cell replacement therapy. Therefore, further investigation into novel approaches for efficient reprogramming is necessary. Here, we show that the lentiviral expression of OCT4 together with SOX2 (OS) driven by a strong spleen focus-forming virus (SFFV) promoter in a single vector can convert 2% of CB CD34+ cells into iPSCs without additional reprogramming factors. Reprogramming efficiency was found to be critically dependent upon expression levels of OS. To generate transgene-free iPSCs, we developed an improved episomal vector with a woodchuck post-transcriptional regulatory element (Wpre) that increases transgene expression by 50%. With this vector, we successfully generated transgene-free iPSCs using OS alone. In conclusion, high-level expression of OS alone is sufficient for efficient reprogramming of CB CD34+ cells into iPSCs. This report is the first to describe the generation of transgene-free iPSCs with the use of OCT4 and SOX2 alone. These findings have important implications for the clinical applications of iPSCs.
机译:通过将CB库转换为iPSC库用于同种异体细胞替代疗法,将脐血(CB)细胞重编程为诱导性多能干细胞(iPSC)具有潜在的再生医学应用。因此,有必要进一步研究有效重新编程的新方法。在这里,我们显示OCT4的慢病毒表达和由强大的脾脏聚焦形成病毒(SFFV)启动子驱动的SOX2(OS)可以在单个载体中将2%的CB CD34 + 细胞转化为没有其他重新编程因素的iPSC。发现重编程效率主要取决于OS的表达水平。为了生成不含转基因的iPSC,我们开发了一种改良的附加型载体,带有土拨鼠转录后调控元件(Wpre),可将转基因表达提高50%。使用该载体,我们仅使用OS就成功生成了无转基因的iPSC。总之,仅OS的高水平表达就足以将CB CD34 + 细胞有效地重编程为iPSC。该报告是第一个描述仅使用OCT4和SOX2即可产生无转基因iPSC的报告。这些发现对iPSC的临床应用具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号